Zacks Investment Research on MSN
AGIO secures global rights to late-stage rare blood disorder candidate
Agios Pharmaceuticals AGIO has inked an agreement with Oscotec, a South Korea-based biotech, in-licensing exclusive global ...
InnoCare Pharma (HKEX: 9969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that the Center for Drug Evaluation (CDE) of ...
Knight Therapeutics Inc., (TSX: GUD) ("Knight") a pan-American (ex-US) pharmaceutical company, announced today the launch of TAVALISSE ® (fostamatinib disodium hexahydrate) in Mexico, for the ...
An oral medication already approved for thrombocytopenia in patients with liver disease significantly improved platelet ...
An oral medication already approved for thrombocytopenia in patients with liver disease significantly improved platelet ...
Researchers sought to determine whether carica papaya leaf extract would improve platelet recovery in patients with chemotherapy-induced thrombocytopenia.
OKLAHOMA CITY — Lakers superstar Luka Doncic spoke to reporters Wednesday for the first time since he suffered a Grade 2 hamstring strain April 2. Doncic revealed what led him to seek treatment in ...
REMOVING BARRIERS TO PSYCHEDELIC DRUGS AS POTENTIAL TREATMENT FOR SERIOUS MENTAL ILLNESS: Today, President Donald J. Trump signed an Executive Order that will accelerate access to treatments for ...
Tyrosine kinase inhibitors (TKIs) have transformed the treatment of chronic myeloid leukemia (CML). In a study involving patients with CML in high-income countries, approximately half the patients who ...
CLL is staged from 0 to 4 using the Rai system based on factors like lymphocyte count and organ enlargement. The earlier stages of CLL, like stage 0 and stage 1, often have a good prognosis and slow ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results